Canton Barry bought DNA
July 28, 2026 · Form 4 insider transaction
Canton Barry bought 117,135 shares of Ginkgo Bioworks Holdings, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
117,135
Price
N/A
Total value
N/A
InsiderCanton Barry
Role—
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateJuly 28, 2026
Filing dateJuly 30, 2026
Shares owned after117,135
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.; The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026.